 |
| April
7, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
The
Most Trusted Contract Vivarium
in Every Bio Hub
Opening in San Diego Fall 2026 |
|
Learn More
→ |
|
|
- Acadia
Pharmaceuticals: DAYBUE STIX (trofinetide) is
Now Broadly Available in the United States for
the Treatment of Rett Syndrome More
- Biocom:
Section 232 Pharmaceutical Tariffs - Statement
More
- Bora
Biologics: Successfully Completes 2,000L
Engineering and Scale-Up Run in San Diego,
Reinforcing Commercial-Scale Readiness More
- Dermata:
Receives Notice of Acceptance of Australian
Patent Application for Topical Application of
Dermal Fillers With Its Bioneedle Delivery
System More
- Illumina:
Changes to Board of Directors More
- LJI:
Scientists Discover How Key Immune Cells
Protect the Prostate More
- Oncolytics
Biotech: Type C FDA Meeting to Discuss
Single-arm Registrational Pathway for
Pelareorep in Anal Cancer More
- Pan
Am Cancer: Expands Global Leadership in
Personalized Cancer Immunotherapy by
Collaboration With Internationally Renowned
Cancer Pioneer Dr. Baofa Yu More
- Revelation
Biosciences: Formation of Acute Kidney Injury
Advisory Board More
- Salk:
Top Cancer Scientist Thales "PapaG"
Papagiannakopoulos Joins Salk Institute More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Acurion: Closes Oversubscribed $4.3
Million Seed Round to Advance AI-Driven
Precision Oncology Platform More
- Artelo Biosciences: Regains Compliance With
Nasdaq Listing Requirements More
- Biocom: Section 232 Pharmaceutical
Tariffs - Biocom Statement More
- Ensysce Biosciences: Secures Second
Financing From 2025 Agreement to Advance
Breakthrough Pain Programs More
- Equillium: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Fate Therapeutics: New Employee Inducement
Award Under Nasdaq Listing Rule 5635(c)(4) More
- Kura Oncology: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- March M&A Surge Triggers High
Expectations for 2026 More
- Neurocrine: Will Acquire Soleno
Therapeutics Expanding Its Endocrinology and
Rare Disease Portfolio More
More
More
More*
- ORIC Pharmaceuticals: Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- UC San Diego School of Medicine Ranked No. 4
Nationally for NIH Funding Among Public
Institutions More
|
|
 |
| San
Diego's turnkey, rentable vivarium
lab space: Start with a few cages
and grow. |
|
Learn More
→ |
|
|
- BioPharmGuy News: Moon Rocket, Fake Masters,
Organ Sacks, Fly Brain, Dead Tortoise More
- Biotech Hangout: Episode 178 Podcast
- ICYMI: How Genalyte is Turning Same-Visit
Diagnostics Into Lifesaving Decisions More
- LJI: Exposing Tumors - Why Some Cancers Are
Especially Hard to Treat More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- 11 Companies Hiring Clinical Professionals
Now More
- Empowering Students through STEM: A
Conversation with Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- Hiring Outlook: January Brings
Year-Over-Year Layoff Decline More
- How Industry Trends are Impacting Hiring
Decisions and Leadership Strategies in Life
Sciences More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- Idorsia Looks for Another CEO — Again;
Former Jazz Exec Makes a Comeback More*
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: San Diego Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:San
Diego, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
